Drug intelligence / Profile preview

HOXC8 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

HOXC8 siRNA refers to small interfering RNA molecules specifically designed to target and silence the expression of the Homeobox C8 (HOXC8) gene. HOXC8 is a transcription factor implicated in various biological processes, including cellular development, differentiation, and tumorigenesis. The mechanism of action involves RNA interference (RNAi), where the siRNA binds to complementary messenger RNA (mRNA) sequences of the HOXC8 gene, leading to the degradation of the mRNA and subsequent inhibition of HOXC8 protein synthesis. This gene silencing approach is utilized in research to investigate the functional roles of HOXC8 in diseases such as cervical cancer, breast cancer, and prostate cancer, where its aberrant expression is often observed. HOXC8 siRNA is primarily used as a research tool to study gene function and explore potential therapeutic strategies by downregulating HOXC8 expression.

02

Targets

HOXC8 (Homeobox protein Hox-C8)

Beyond the preview

Go deeper on HOXC8 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOXC8 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call